We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01167205
Recruitment Status : Unknown
Verified July 2010 by Seoul National University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : July 22, 2010
Last Update Posted : July 22, 2010
Sponsor:
Collaborator:
Ministry of Health & Welfare, Korea
Information provided by:
Seoul National University Hospital

Brief Summary:
The purpose of this study is to determine whether astaxanthin (ASX) supplementation will reduce obesity-induced oxidative stress and improve lipid profile in overweight and obese adults.

Condition or disease Intervention/treatment
Healthy Overweight Obesity Dietary Supplement: astaxanthin

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Study Start Date : August 2010
Estimated Primary Completion Date : December 2010
Estimated Study Completion Date : March 2011

Resource links provided by the National Library of Medicine

Drug Information available for: Astaxanthin
U.S. FDA Resources


Intervention Details:
    Dietary Supplement: astaxanthin
    astaxanthin 20mg for 12 weeks


Primary Outcome Measures :
  1. Evaluation of the plasma MDA (malonaldehyde) level [ Time Frame: 12 weeks ]

    MDA is a three chain aldehyde produced during the composition of a lipid hydroperoxide and is a well known indicator of lipid peroxidation.

    The purpose of this stduy is to determine whether ASX supplementation lowers oxidative stress using MDA,a biomarker.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Subjects with BMI over 25.0 kg/m2
  • Non-smoker

Exclusion Criteria:

  • Excessive alcohol consumption
  • Pregnant or lactating women
  • Dyslipidemia, hyperglycemia, or other chronic diseases.
  • Subjects who were taking vitamin supplements

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01167205


Contacts
Contact: Yeo-kyu Youn, Doctor +82 2 2072 3447 ykyoun@snu.ac.kr

Locations
Korea, Republic of
Clinical Research Institute Seoul National University Hospital Not yet recruiting
Seoul, Korea, Republic of, 110-744
Contact: Wan Gyoon Shin, Ph D, Pharm D    +82 2 740 85556    wgshin@snu.ac.kr   
Sponsors and Collaborators
Seoul National University Hospital
Ministry of Health & Welfare, Korea

ClinicalTrials.gov Identifier: NCT01167205     History of Changes
Other Study ID Numbers: C-1005-072-319
First Posted: July 22, 2010    Key Record Dates
Last Update Posted: July 22, 2010
Last Verified: July 2010

Keywords provided by Seoul National University Hospital:
Healthy adults with BMI over 25.0 kg/m2

Additional relevant MeSH terms:
Overweight
Body Weight
Signs and Symptoms